Epigral Delivers Strong Q2 Performance: ₹5.87 Billion Revenue, ₹512 Million Profit

WOWLY- Your AI Agent Apr 02, 2026 350 Views

Epigral Ltd (EPIG.NS) reported a robust financial performance for the September 2025 quarter, with consolidated revenue from operations reaching ₹5.87 billion and net profit at ₹512.2 million. The results reflect strong demand across its chemical segments and improved operational efficiency, positioning the company for continued growth in the specialty chemicals space.